New MIPI Alliance Group Collaborates with Automotive Industry Experts to Address Interface Specifications for Automotive Applications
The MIPI® Alliance, an international organization that develops interface specifications for mobile and mobile-influenced industries, today announced the formation of an Automotive Birds of a Feather (BoF) Group to solicit industry input from original equipment manufacturers (OEMs) and their suppliers to enhance existing or develop new interface specifications for automotive applications. The group is open to both MIPI Alliance member and non-member companies to represent the broader automotive ecosystem.
Automobiles have become a new platform for innovation, and manufacturers are already using MIPI Alliance specifications as they develop and implement applications for passive and active safety, infotainment and advanced driver assistance systems (ADAS). MIPI interfaces such as Camera Serial Interface 2 (MIPI CSI-2SM), Display Serial Interface (MIPI DSISM) and Display Serial Interface 2 (MIPI DSI-2SM) are ideal for a variety of low- and high-bandwidth applications that integrate components such as cameras, displays, biometric readers, microphones and accelerometers. MIPI I3CSM helps automotive systems designers minimize the complexity, cost and development time for products that use multiple sensors in a space-constrained form factor. Highly sensitive, mission-critical automotive applications also benefit from MIPI interfaces’ low electromagnetic interference (EMI), a capability that’s been proven in billions of mobile phones and other handheld devices.
“Automakers already rely on MIPI Alliance’s industry-standard interfaces to enable a wide variety of applications, including collision mitigation and avoidance, infotainment and navigation,” said Matt Ronning, chair of the MIPI Alliance Automotive Subgroup and the Automotive BoF. “This call for participation helps ensure we cast a wide net to capture expertise to aid with extending existing and shape future MIPI specifications and collectively help realize the vision of how connected cars and automotive applications will evolve over the next decade. Just as mobile handset manufacturers benefited from the standardization that MIPI Alliance has provided, automotive OEMs would similarly benefit.”
“Active participation of automotive OEMs, tier-one and tier-two suppliers is greatly appreciated and necessary to, for example, work out the data link requirements between surround sensors, electronic control units, actors and displays for driver assistance and autonomous driving projects beyond 2020 and incorporate them into MIPI interface specifications,” said Uwe Beutnagel-Buchner, vice-chair of the MIPI Alliance Automotive Subgroup and the Automotive BoF.
For short-distance communications (< 0.3 meters), the MIPI CSI specification is the most widely adopted in automotive camera applications; MIPI DSI is rapidly gaining adoption also. The Automotive BoF Group’s initial focus will be to examine how MIPI specifications can potentially be extended to support communication link distances up to 15 meters, and at the same time support the high data rates associated with cameras and radar sensors for autonomous driving systems.
Join the MIPI Alliance Automotive BoF Group
The MIPI Automotive BoF is seeking additional qualified experts from OEMs, tier-one suppliers, component suppliers and related companies to provide key input into current and future MIPI interface specifications. The Automotive BoF is expected to convene via teleconference on a biweekly basis, with face-to-face meetings planned as necessary.
Companies already participating in MIPI Alliance’s Automotive BoF Group include: Analog Devices, Inc.; Analogix Semiconductor, Inc.; BitSim AB; BMW Group; Cadence Design Systems, Inc.; Continental Corporation; Etron Technology, Inc.; Ford Motor Company; Genesys Logic, Inc.; Hardent Inc.; Lontium Semiconductor Corporation; Microchip Technology Inc.; Mixel, Inc.; Mobileye, an Intel Company; NVIDIA; NXP Semiconductors; ON Semiconductor; Parade Technologies Ltd.; Qualcomm Incorporated; Robert Bosch GmbH; Sony Corporation; STMicroelectronics; Synopsys, Inc.; TE Connectivity Ltd.; Tektronix Inc.; Teledyne LeCroy; Texas Instruments Incorporated; Toshiba Corporation; Western Digital and others.
To learn more and submit an interest form, visit: http://bit.ly/2wOqycY
To discover more about MIPI Alliance and to connect with its social networks, follow its Twitter and Facebook pages and join its LinkedIn group. To join MIPI Alliance, use the Join MIPI link on the organization’s website.
About MIPI Alliance
MIPI Alliance (MIPI) develops interface specifications for mobile and mobile-influenced industries. There is at least one MIPI specification in every smartphone manufactured today. Founded in 2003, the organization has over 300 member companies worldwide and 13 active working groups delivering specifications within the mobile ecosystem. Members of the organization include handset manufacturers, device OEMs, software providers, semiconductor companies, application processor developers, IP tool providers, test and test equipment companies, as well as camera, tablet and laptop manufacturers. For more information, please visit www.mipi.org.
MIPI® is a registered trademark owned by MIPI Alliance. MIPI CSI-2 SM , MIPI DSI SM , MIPI DSI-2 SM and MIPI I3C SM are service marks of MIPI Alliance. All other marks are the property of their respective owners.
Interprose for MIPI Alliance
Lisa McCausland, +1 303-888-2137
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting21.10.2018 01:30 | Tiedote
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents. The data, which are being presented as a late-breaking poster at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting in Chicago, suggest filgotinib has a potential role in addressing important unmet needs in the treatment of rheumatoid arthritis. Positive efficacy data from FINCH 2 were previously announced in September 2018. The data show statistically significant improvements in the proportion of patients achieving a range of clinical efficacy endpoints, including the proportion of patients achieving American College of Rheumatology 20 percent (ACR20, primary endpoint), 50 percent
Manchester United and True Religion Launch Denim Range19.10.2018 20:37 | Tiedote
Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion
Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10 | Tiedote
Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54 | Tiedote
Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr
Tradeshift Announces Q3 2018 Results19.10.2018 14:00 | Tiedote
Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme